Boehringer Ingelheim Obesity Drug Shows Fat-Specific Weight Loss in Late-Stage Trial

Late-stage trial results for Boehringer Ingelheim's obesity drug indicate that it helps patients lose fat rather than muscle, a key finding for weight-loss treatments.

30 Apr, 06:17 — 30 Apr, 06:17

Post Share

Sources

Showing 1 of 1 sources

wsjHigh122d ago

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows - WSJ

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows WSJ

Read full article →

Boehringer Ingelheim Obesity Drug Shows Fat-Specific Weight Loss in Late-Stage Trial

Sources

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows - WSJ

Related Stories

NASA Launches Nancy Grace Roman Space Telescope to Probe Dark Universe

Rescued Orangutan Battles Respiratory Illness After Borneo Wildfires

NASA Launches Nancy Grace Roman Space Telescope on Planet-Hunting Mission

Scientists Investigate Herpes Virus Link to Mass Sardine Die-Off Off South Africa